EGM
ACRS icon

Engineers Gate Manager’s Aclaris Therapeutics ACRS Stock Holding History

Engineers Gate Manager’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.6K Buy
+18,294
New +$61.7K ﹤0.01% 2064
2025
Q4 		– Sell
-17,844
Closed -$33.9K – 2056
2025
Q3 		$33.9K Buy
17,844
+255
+1% +$445 ﹤0.01% 2085
2025
Q2 		$25K Sell
17,589
-22,653
-56% -$30.7K ﹤0.01% 2089
2025
Q1 		$61.6K Sell
40,242
-53,305
-57% -$114K ﹤0.01% 2036
2024
Q4 		$232K Buy
93,547
+54,753
+141% +$136K ﹤0.01% 1835
2024
Q3 		$44.6K Sell
38,794
-21,742
-36% -$26.7K ﹤0.01% 1988
2024
Q2 		$66.6K Buy
60,536
+3,398
+6% +$3.99K ﹤0.01% 1788
2024
Q1 		$70.9K Sell
57,138
-22,651
-28% -$27K ﹤0.01% 1779
2023
Q4 		$83.8K Buy
79,789
+54,319
+213% +$166K ﹤0.01% 1799
2023
Q3 		$174K Buy
+25,470
New +$218K 0.01% 1518
2023
Q2 		– Sell
-21,725
Closed -$176K – 1695
2023
Q1 		$176K Buy
+21,725
New +$276K 0.01% 1451
2022
Q1 		– Sell
-27,453
Closed -$399K – 1795
2021
Q4 		$399K Buy
+27,453
New +$416K 0.02% 1216
2021
Q3 		– Sell
-24,532
Closed -$431K – 1591
2021
Q2 		$431K Buy
24,532
+3,530
+17% +$80.2K 0.03% 922
2021
Q1 		$529K Buy
21,002
+7,095
+51% +$139K 0.03% 960
2020
Q4 		$90K Buy
+13,907
New +$58.7K ﹤0.01% 1594

Other funds holding ACRS

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Engineers Gate Manager's ACRS Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Aclaris Therapeutics (ACRS) in Q1 2026: 18,294 shares worth $68.6K. The stake represents ﹤0.01% of the portfolio and ranks #2064 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in ACRS as recently as Q3 2025.

Engineers Gate Manager first reported a position in ACRS in Q4 2020 and has held it in 15 quarters since. The position peaked at $529K in Q1 2021. 136 funds tracked by Wall St. Rank hold ACRS as of Q1 2026.

  • Engineers Gate Manager held 18,294 shares of Aclaris Therapeutics worth $68.6K as of Q1 2026.
  • Aclaris Therapeutics was a new Engineers Gate Manager position in Q1 2026.
  • Aclaris Therapeutics made up ﹤0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #2064 holding.
  • Engineers Gate Manager first reported a position in Aclaris Therapeutics in Q4 2020 and has held it in 15 quarters since.
  • Engineers Gate Manager's Aclaris Therapeutics position peaked at $529K in Q1 2021.
  • 136 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.